Structure Therapeutics (GPCR) Tax Rate (2022 - 2026)
Quarterly Tax Rate fell 4.0% to 0.25% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 2.37% through Mar 2026, down 208.0% year-over-year, with the annual reading at 15.19% for FY2025, 1547.0% up from the prior year.
Structure Therapeutics' Tax Rate history spans 5 years, with the latest figure at 0.25% for Q1 2026.
- Tax Rate came in at 0.25% for Q1 2026, down from 0.1% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 3.59% in Q4 2022 to a low of 1.73% in Q3 2023.
- The 5-year median for Tax Rate is 0.25% (2026), against an average of 0.16%.
- Year-over-year, Tax Rate tumbled -419bps in 2023 and then surged 146bps in 2024.
- Structure Therapeutics' Tax Rate stood at 3.59% in 2022, then crashed by -116bps to 0.59% in 2023, then increased by 16bps to 0.5% in 2024, then skyrocketed by 119bps to 0.1% in 2025, then plummeted by -361bps to 0.25% in 2026.
- Per Business Quant, the three most recent readings for GPCR's Tax Rate are 0.25% (Q1 2026), 0.1% (Q4 2025), and 0.16% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 56.85 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 5.61 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 17.68 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 12.51 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | -6.79 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 7.07 |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | -0.25 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.25% |
| Mar 31, 2026 | -0.25% |
| Dec 31, 2025 | 0.10% |
| Dec 31, 2025 | 0.10% |
| Sep 30, 2025 | -0.16% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.23% |
| Jun 30, 2025 | -0.23% |
| Mar 31, 2025 | -0.21% |
| Mar 31, 2025 | -0.21% |
| Dec 31, 2024 | -0.50% |
| Dec 31, 2024 | -0.50% |
| Sep 30, 2024 | -0.27% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | -0.20% |
| Jun 30, 2024 | -0.20% |
| Mar 31, 2024 | -0.11% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | -0.59% |
| Dec 31, 2023 | -0.59% |
| Sep 30, 2023 | -1.73% |
| Sep 30, 2023 | -1.73% |
| Jun 30, 2023 | -0.51% |
| Jun 30, 2023 | -0.51% |
| Mar 31, 2023 | -0.14% |
| Mar 31, 2023 | -0.14% |
| Dec 31, 2022 | 3.59% |
| Dec 31, 2022 | 3.59% |
| Sep 30, 2022 | -0.59% |
| Sep 30, 2022 | -0.59% |
| Jun 30, 2022 | -0.46% |
| Jun 30, 2022 | -0.46% |
| Mar 31, 2022 | -0.46% |
| Mar 31, 2022 | -0.46% |